MG217 Multi-Symptom Treatment Cream & Skin Protectant… was recalled on April 24, 2026 in cooperation with the U.S. Food and Drug Administration because microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus..
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Lot #: 1024088, Exp 11/30/2026
Units affected: 690 tubes
Where it was sold: USA Nationwide and Bahamas
Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Class I is the most serious FDA recall level: using or being exposed to the product could cause serious health problems or death.
Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.
Contact: Recalling firm: Wisconsin Pharmacal Company
Not sure what you're entitled to? Read our guide: what to do if your product is recalled.
Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.
View official notice →The snubber circuit can emit flames if it shorts, posing a risk of serious injury due to fire hazard.
The black eyes can detach from the recalled teether if frozen, posing a risk of serious injury or death from a choking hazard.
The lithium-ion battery in the recalled power banks can overheat and ignite, posing fire and burn hazards to consumers.
The glued knot on the elastic cord can become untied on the recalled product, allowing young children access to the small wooden and plastic pieces, posing a risk of serious injury or death from choking and ingestion hazards.
Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.